>>>DR. JAY HARNESS: In talking about ductal carcinoma in situ (DCIS), there are various things that go into the description of DCIS. The number one thing that we talk about is the...
>>> Dr. Margileth: Whenever we see a breast cancer, we do testing of estrogen receptor, progesterone receptor, and a growth regulatory gene called HER2/neu gene. One of the more...

1

annotations

Steven Shak, MD>>> Steve Shak, MD: The Oncotype DX breast cancer test informs your team about the individual biology of your tumor and by understanding that, their discussion with...

1

annotations

Todd Hartley: These are Dr. Harness’s 15 questions that are available to any of you. If you like to go to the website, download it, print it out, bring it with you when you meet with your physician....

1

annotations

>>>Dr. Margileth: There was a trial called the ATAC trial that was reported in 2005 whose findings were that in postmenopausal women in the adjuvant therapy of breast cancer five...
>>>Dr. Michael Schultz: Having used the Oncotype DX for my invasive cancers for over six years, the natural progression to the DCIS recurrence score was really quite easy because...

1

annotations

This research article is titled "Dclk1 distinguishes between tumor and normal stem cells in the intestine" it was published by the Chiba lab at Kyoto University in Kyoto Japan in...
[MUSIC] GIBBS: DNA Sequencing is a process where we determine and identify every single DNA base, every single DNA element that is in the genome of an individual. There are six billion of those in...
How is the Oncotype DX Assay USed in Planning the Treatment for Patients with DCIS? Let me share with you some thoughts on that subject. The Oncotype DX assay has been available now for several years....

1

annotations